mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0009 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.001 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |